| |
| |
Series Foreword | |
| |
| |
Preface | |
| |
| |
Acknowledgments | |
| |
| |
| |
An Uneasy Balance: Science Advising and the Politicization of Science | |
| |
| |
| |
Big Science: The Human Genome Project and the Public Funding of Science | |
| |
| |
Funding Biomedical Research: Peer Review versus Pork Barrel | |
| |
| |
Choosing Research Directions: Advocacy, the "Disease-of-the-Month," and Congressional Oversight | |
| |
| |
| |
Who Owns the Genome? The Patenting of Human Genes | |
| |
| |
Who Owns Life? Mr. Moore's Spleen | |
| |
| |
The Canavan Disease Patent Case | |
| |
| |
| |
Manufacturing Children: Assisted Reproductive Technologies and Self-Regulation by Scientists and Clinicians | |
| |
| |
Brave New World Revisited: Human Cloning and Stem Cells | |
| |
| |
The Asilomar Conference on Recombinant DNA: A Model for Self-Regulation? | |
| |
| |
| |
Protecting the Public: The FDA and New AIDS Drugs | |
| |
| |
Seminal Events: The Evolution of Regulations for Research | |
| |
| |
Placebo Controls in Clinical Research | |
| |
| |
| |
Cosmetic Science: Breast Implants and the Courts | |
| |
| |
Setting Limits on Expert Testimony: Bendectin and Birth Defects | |
| |
| |
DNA Forensics in Criminal Trials: How New Science Becomes Admissible | |
| |
| |
| |
Selling Science: New Cancer Treatments and the Media | |
| |
| |
Responsible Journalism: Are There Health Risks from Electromagnetic Fields? | |
| |
| |
| |
Concealing Evidence: Science, Big Business, and the Tobacco Industry | |
| |
| |
The Academic-Industrial Complex and Conflict of Interest | |
| |
| |
The Darker Side of Science: Scientific Misconduct | |
| |
| |
| |
Science in the National Interest: Bioterrorism and Civil Liberties | |
| |
| |
Emerging Diseases: SARS and Government Responses | |
| |
| |
Limiting Research in an Age of Bioterrorism | |
| |
| |
| |
Science Misunderstood: Genetically Modified Organisms and International Trade | |
| |
| |
Mad Cow Disease, International Trade, and the Loss of Public Trust | |
| |
| |
| |
Dangers in the Environment: Air Pollution Policy | |
| |
| |
Environmental Poisoning: Mitigating Lead Exposure | |
| |
| |
Can We Ever Be Safe? Risk and Risk Assessment | |
| |
| |
| |
Who Lives and Who Dies? Organ Transplantation | |
| |
| |
Animals as Organ Factories: Xenotransplantation | |
| |
| |
Is There a Right to Die? | |
| |
| |
| |
Concluding Remarks: The Challenges of Science Policy | |
| |
| |
Index | |